share_log

Stifel Upgrades Profound Medical to Buy, Raises Price Target to $12

Stifel Upgrades Profound Medical to Buy, Raises Price Target to $12

Stifel将Profound Medical升级为买入评级,将目标价提高至12美元
Benzinga ·  07/16 05:30

Stifel analyst Rick Wise upgrades Profound Medical (NASDAQ:PROF) from Hold to Buy and raises the price target from $9 to $12.

Stifel分析师里克·怀斯将Profound Medical(纳斯达克股票代码:PROF)从持有上调至买入,并将目标股价从9美元上调至12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发